Skip to main content

Containment and case management of COVID-19 pandemic

Guest edited by Dr Jürg Utzinger, Prof Albert Ko, Dr Robert Bergquist, Dr Florence Fouque and Dr Xiao-Nong Zhou


On 11 March 2020, the World Health Organization (WHO) described the coronavirus disease 2019 (COVID-19) situation as a pandemic. As of 12 April 2020, 1,695,096 confirmed cases, with 105,865 deaths of COVID-19 have been reported to WHO from more than 211 countries/territories of the world. In order to mitigate threat and impact of COVID-19 on health and society, the international community has stand ready to respond to the pandemic.

Several countries have demonstrated that COVID-19 transmission can be slowed or stopped. The urgent and significant strategies may be to limit human-to-human transmission, identify and manage cases, address crucial questions regarding clinical severity and treatment options, as well as accelerate the development of diagnostics, therapeutics, and vaccines. This may be accomplished by improving the level of and scaling up preparedness and response operations, including strengthening readiness to rapidly identify, diagnose and treat cases; to identify and follow-up close contacts; and to raise awareness on other countermeasures. Case management should include considerations for individual quarantine, clinical treatment of confirmed symptomatic cases and home care for suspected mild infections. Accelerating priority research and innovation in candidate therapeutics, vaccines, and diagnostics will facilitate the multidisciplinary and collaborative response.

In order to rapidly share scientific evidence and experiences acquired in studies regarding above strategies within the international communities, Infectious Diseases of Poverty is launching a new Thematic Series entitled Containment and case management of COVID-19 pandemic. The themes covered in this series include but not limited to preparedness and response strategies, case identification and management, clinical diagnosis and treatment, research and innovation in therapeutics, vaccines, and diagnostics as well as any subject closely related. Various article types are welcomed, including Scoping Review, Research Article, Case Report, Case Study, Commentary, Letter to the Editor, Opinion, Short Report, and Study Protocol. Manuscripts submitted to this Thematic Series will be rapidly published online once approved by a very quick peer review.

Submission instructions

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Infectious Diseases of Poverty.

The complete manuscript should be submitted through the journal submission system.

To ensure that you submit to the correct thematic series, please select the appropriate section in the drop-down menu upon submission.

Read the published articles for this series. 

Annual Journal Metrics

  • 2022 Citation Impact
    8.1 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.984 - SNIP (Source Normalized Impact per Paper)
    1.692 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    118 days submission to accept (Median)

    2023 Usage
    1,127 Altmetric mentions